Association of Axin2 S2240308 C>T, Rs1133683 C>T, Rs7224837 A>G Polymorphisms With Susceptibility to Breast Cancer Publisher Pubmed



Sayad S¹ ; Abdigamsae M² ; Jafarinedooshan J³ ; Farbod M⁴ ; Dastgheib SA⁵ ; Karimizarchi M^{6, 7} ; Asadian F⁸ ; Neamatzadeh H^{9, 10}
Source: Asian Pacific journal of cancer prevention : APJCP Published:2021

Abstract

BACKGROUND: The association of genetic polymorphisms at Axis inhibition protein 2 (AXIN2) gene and susceptibility to different cancer has attracted much interest. The present study aimed to evaluate the association between AXIN2 rs2240308 C>T, rs1133683 C>T, rs7224837 A>G polymorphisms with susceptibility to breast cancer. METHODS: A polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay was designed to genotype the AXIN2 rs2240308 C>T, rs1133683 C>T, rs7224837 A>G polymorphisms among 150 breast cancer patients and 150 healthy subjects. RESULTS: The frequencies of these genetic variants were in agreement with Hardy-Weinberg equilibrium in healthy controls (p>0.05). The frequencies of AXIN2 rs2240308 C>T, rs1133683 C>T, rs7224837 A>G genotypes were similar in breast cancer patients and controls. There was no a significant association between the AXIN2 SNP and risk of breast cancer. CONCLUSION: The impact of AXIN2 polymorphisms in the breast cancer development remains unclear. Our results indicated that AXIN2 rs2240308, rs7224837 and rs1133683 polymorphisms did not contribute to increased risk of breast cancer. More studies with larger sample sizes and diverse ethnicities are warranted to verify our finding.